Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BICO & VITK -- Ignore unavailable to you. Want to Upgrade?

To: JS who wrote (2089)	8/4/1998 11:43:00 PM
From: Tom R. Jones	Respond to of 2395

As an oldtimer with BICO, I can tell you that we will soon see a PR that says: "BICO is pleased to announce that the meeting with the FDA was very encouraging. The FDA representatives were impressed with the fact that BICO received the CE Mark and completed the home testing of the Diasensor. The FDA will study the data in the coming months and schedule another meeting for the purpose of approving the Diasensor in the US." The PR might or might not say: "Management is convinced that once the FDA sees that data, it will approve the Diasensor for use in the US." The reason that statement might not appear in the PR is because the shareholder lawsuit is based on those kinds of statements from BICO. All this is just my opinion...Tom